VYNE Therapeutics Inc. (VYNE)
1.69
-0.09 (-5.06%)
At close: Mar 28, 2025, 3:59 PM
1.69
0.00%
After-hours: Mar 28, 2025, 04:37 PM EDT
VYNE Therapeutics Ratios Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| PE Ratio | -3.58 | -0.84 | -0.25 | -0.72 | -0.8 | -2.23 | -1.74 | -20.34 | -23.55 | -71.89 |
| PEG Ratio | 0.05 | 0.01 | 0.00 | 0.01 | 0.16 | 0.18 | -0.03 | -1.29 | -0.11 | n/a |
| PS Ratio | 284.78 | 56.45 | 18.03 | 3.56 | 9.76 | 355.49 | 8.39 | 129.04 | 491.53 | n/a |
| PB Ratio | 2.74 | 0.27 | 0.28 | 1.08 | 5.46 | 2.30 | 0.68 | -10.37 | -11.25 | -20.77 |
| P/FCF Ratio | -4.19 | -0.94 | -0.29 | -0.93 | -1.49 | -2.42 | -1.69 | -20.91 | -142.67 | -79.2 |
| P/OCF Ratio | -4.2 | -0.94 | -0.29 | -0.93 | -1.49 | -2.42 | -1.69 | -20.93 | -144.6 | -79.2 |
| OCF/S Ratio | -67.81 | -59.77 | -61.22 | -3.82 | -6.53 | -146.95 | -4.96 | -6.16 | -3.4 | n/a |
| Debt / Equity Ratio | 0.00 | 0.00 | -0.01 | 0.01 | 0.93 | 0.01 | n/a | n/a | n/a | n/a |
| Quick Ratio | 4.35 | 12.73 | 4.09 | 3.04 | 3.72 | 7.22 | 14.62 | 8.55 | 8.08 | 56.99 |
| Current Ratio | 4.35 | 12.73 | 4.10 | 3.43 | 4.07 | 7.35 | 14.62 | 8.17 | 8.08 | 56.99 |
| Asset Turnover | 0.01 | 0.00 | 0.01 | 0.22 | 0.22 | 0.01 | 0.08 | 0.07 | 0.02 | n/a |
| Interest Coverage | n/a | n/a | n/a | -12.13 | -25.85 | -30.03 | -17.65 | -57.24 | n/a | n/a |
| Return on Equity (ROE) | -0.76 | -0.32 | -1.09 | -1.51 | -6.82 | -1.03 | -0.39 | 0.51 | 0.48 | 0.29 |
| Return on Assets (ROA) | -0.6 | -0.29 | -0.83 | -1.09 | -2.73 | -0.89 | -0.37 | -0.43 | -0.33 | -0.11 |
| Return on Capital (ROIC) | -0.84 | -0.32 | -1.09 | -1.4 | -1.57 | -1.11 | -0.42 | -0.5 | -0.38 | -0.11 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 100.00% | 100.00% | 100.00% | 77.31% | 93.37% | 20.99% | 100.00% | 100.00% | 100.00% | n/a |
| Net Profit Margin | -7.95K% | -6.71K% | -7.12K% | -496.98% | -1.22K% | -15.91K% | -483.51% | -634.57% | -2.09K% | n/a |
| Pretax Profit Margin | -7.94K% | -6.57K% | -7.11K% | -500.01% | -1.22K% | -16.64K% | -483.51% | -634.57% | -2.09K% | n/a |
| Operating Profit Margin | -8.71K% | -6.9K% | -7.19K% | -461.08% | -540.54% | -17.21K% | -512.55% | -645.85% | -2.13K% | n/a |
| FCF Margin | -6.8K% | -5.98K% | -6.12K% | -382.02% | -653.53% | -14.7K% | -496.93% | -617.07% | -344.51% | n/a |
| EBITDA Margin | -8.71K% | -6.9K% | -7.17K% | -263.89% | -1.2K% | -21.24K% | -512.55% | -645.85% | -2.13K% | n/a |